Spending bill should require FDA to clarify genome editing policy, lawmakers say
The 2023 appropriations legislation currently under debate in Congress should require the U.S. Food and Drug Administration (FDA) to clarify its policy on genome […]
Spending bill should require FDA to clarify genome editing policy, lawmakers say Read More »